This apparent contradiction likely reflects complex immunoregulatory cascades whereby NUCB2‐expressing tumour cells secrete immunomodulatory factors that initially promote T‐cell activation but subsequently induce exhaustion phenotypes. Here, NUCB2 is linked to neoplasm.